• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

139
16
13
13
10

COUNTRY

13
3
2
1
1

PRICE

58
125
168
357

PUBLISHED

7
12
79
357

PRODUCT TYPE

343
10
4

Respiratory

Respiratory drugs and is a growing sector of the pharmaceuticals industry, and we have all the information resources that you need to be a leading player in this lucrative market. The publications listed under Research and Markets’ Respiratory category cover all drugs and therapeutics for conditions and diseases relating to the lungs and/or breathing, such as Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, COPD (chronic obstructive pulmonary disease), cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, sleep apnea and others.

Our reports, books, and subscriptions will provide you with the latest industry news, forecasts, market trends and company profiles of market leaders and niche players including: Accentia Biopharmaceuticals, Aerogen, Aerovance, airPharma, AstraZeneca, Aventis Pharma, Bespak, Boehringer Ingelheim Pharmaceuticals, Cadila Pharmaceuticals, Dr. Reddys Laboratories, EvoGenix, GlaxoSmithKlineInyx, The Merck Generics Group, Novartis AG, Pfizer, Ranbaxy Laboratories, Respironics, Sandoz International, Schering-Plough, etc.

Publications on smoking cessation are listed under the OTC sub-category in the Pharmaceuticals section. Show Less
Read more

PRODUCT TITLE
Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 Bronchopulmonary Dysplasia - Pipeline Review, H1 2013 - Product Thumbnail Image

Bronchopulmonary Dysplasia - Pipeline Review, H1 2013

Bronchopulmonary Dysplasia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bronchopulmonary Dysplasia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily...

April 2013
FROM

Bronchospasm Global Clinical Trials Review, H1, 2013

Bronchospasm Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Bronchospasm Global Clinical Trials Review, H1, 2013" provides data on the Bronchospasm clinical trial scenario....

April 2013
FROM
Cystic Fibrosis - Pipeline Review, H1 2013 Cystic Fibrosis - Pipeline Review, H1 2013 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Review, H1 2013

Cystic Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cystic Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM

Nasal Congestion Global Clinical Trials Review, H1, 2013

Nasal Congestion Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Nasal Congestion Global Clinical Trials Review, H1, 2013" provides data on the Nasal Congestion clinical...

March 2013
FROM

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022

EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022 Cystic fibrosis (CF) is the most common inherited rare disease in North America and Europe, with more than 27,000 cases in the US and...

March 2013
FROM
Perennial Allergic Rhinitis - Pipeline Review, H1 2013 Perennial Allergic Rhinitis - Pipeline Review, H1 2013 - Product Thumbnail Image

Perennial Allergic Rhinitis - Pipeline Review, H1 2013

Perennial Allergic Rhinitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Perennial Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

March 2013
FROM
Lung Disease - Pipeline Review, H1 2013 Lung Disease - Pipeline Review, H1 2013 - Product Thumbnail Image

Lung Disease - Pipeline Review, H1 2013

Lung Disease – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Lung Disease - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2013 Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2013 - Product Thumbnail Image

Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2013

Respiratory Tract Inflammatory Disorders – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2013', provides an overview of...

March 2013
FROM
Bronchiectasis - Pipeline Review, H1 2013 Bronchiectasis - Pipeline Review, H1 2013 - Product Thumbnail Image

Bronchiectasis - Pipeline Review, H1 2013

Bronchiectasis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Bronchiectasis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Prostate Cancer - Pipeline Review, H1 2013 Prostate Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Prostate Cancer - Pipeline Review, H1 2013

Prostate Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Prostate Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

March 2013
FROM
Candidiasis - Pipeline Review, H1 2013 Candidiasis - Pipeline Review, H1 2013 - Product Thumbnail Image

Candidiasis - Pipeline Review, H1 2013

Candidiasis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Candidiasis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

March 2013
FROM
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013 - Product Thumbnail Image

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2013

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review,...

March 2013
FROM
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013 Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013

Idiopathic Pulmonary Fibrosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

February 2013
FROM

Sleep Apnea Global Clinical Trials Review, H1, 2013

Sleep Apnea Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Sleep Apnea Global Clinical Trials Review, H1, 2013" provides data on the Sleep Apnea clinical trial scenario....

February 2013
FROM
Allergic Rhinitis - Pipeline Review, H1 2013 Allergic Rhinitis - Pipeline Review, H1 2013 - Product Thumbnail Image

Allergic Rhinitis - Pipeline Review, H1 2013

Allergic Rhinitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Allergic Rhinitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report...

February 2013
FROM
Chronic Bronchitis - Pipeline Review, H1 2013 Chronic Bronchitis - Pipeline Review, H1 2013 - Product Thumbnail Image

Chronic Bronchitis - Pipeline Review, H1 2013

Chronic Bronchitis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Chronic Bronchitis - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This...

February 2013
FROM

EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022

EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022 Summary Respiratory syncytial virus (RSV) is one of the most...

February 2013
FROM
Competing in the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players Competing in the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players - Product Thumbnail Image

Competing in the Global Respiratory Disease Testing Market: Emerging Tests, Technology Assessment, Instrumentation Review, Market Shares, Sales Forecasts by Country, Strategic Profiles of Key Players

This new 366-page report from Venture Planning Group contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation,...

February 2013
FROM

Bronchiectasis Global Clinical Trials Review, H1, 2013

Bronchiectasis Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Bronchiectasis Global Clinical Trials Review, H1, 2013" provides data on the Bronchiectasis clinical trial...

February 2013
FROM
Loading Indicator

Our Clients

Our clients' logos